RSC Advances
Paper
ml) were placed in a screw-capped vial equipped with a
magnetic stirrer. Next, the mixture was stirred at 30 uC for 18
h, then CH2Cl2 was added (1 ml), and the catalyst recovered by
filtration. The mixture was subsequently diluted with CH2Cl2
(2 ml), washed with water (3 ml 6 2), dried over Na2SO4,
filtered and evaporated to dryness to afford pure 6 (99% yield,
uC. After 18 h, the crude mixture was diluted with CHCl3 (2
ml), the catalyst was filtered off, and the solvent removed
under vacuum to give 9-bromo-10-[4-hexyloxy-(3-nitropheny-
l)ethynyl]anthracene 8. This latter was purified by re-crystal-
lization from ethyl acetate (2 6 25 ml) to give the pure
compound as yellow needles (0.176 g, 90% yield). 1H NMR
(CDCl3, d): 8.67 (m, 3H), 8.53 (m, 3H), 7.63 (m, 4H), 6.96 (m,
1H), 4.05(m, 2H), 1.83 (m, 4H) 1.42 (m, 4H), 0.87 (m, 3H); 13C
NMR (CDCl3, d): 153.5, 142.4, 140.9, 134.5, 134.4, 134.2, 130.9,
130.1, 126.3, 124.6, 118.4, 113.9, 114.9, 95.6, 87.7, 70.5, 31.5,
29.3, 25.6, 22.6, 14. An. Calcd. For: C28H24BrNO3: C, 66.94; H,
4.82; N, 2.79%. Found: C, 66.89; H, 4.83; N, 2.77%. E-factor =
[0.106 g (4-ethynyl-1-(hexyloxy)-2-nitrobenzene) + 0.149 g (9-
iodo-,10-bromoanthracene) + 0.57 g (cyclopentyl methyl ether)
+ 0.00074 g (CuI) + 1.063 g (diisopropylamine) + 0.029 g
(PdEnCat30) + 2.98 g (CHCl3) + 45.10 g (ethyl acetate) 2 0.176 g
(product 6 yield)]/0.176 g = 283.0.
1
yellow oil). H NMR (CDCl3, d): 7.93 (d, J = 2.4 Hz, 1H), 7.61
(dd, J = 2.4, 8.9 Hz, 1H), 6.95 (d, J = 8.9 Hz, 1H), 4.09 (m, 2H),
1.90 (m, 4H), 1.43(m, 4H), 0.89 (m, 3H). 13C NMR (CDCl3, d):
153.6, 140.5, 137.24, 129.14, 117.30, 113.5, 99.9, 94.3, 70.6,
31.5, 29.4, 25.6, 22.6, 14.0, 20.3. E-factor = [0.174 g (4-
(hexyloxy)-3-nitro-iodobenzene) + 0.076 g (diisopropylamine) +
0.408 g (2-methyl-THF) + 0.1474 g (trimethylsilylacetylene) +
0.0019 g (CuI) + 0.025 (PdEnCatTPP30) + 3.97 g (CH2Cl2) + 6.0 g
(H2O) 2 0.158 g (product 6 yield)]/0.158 g = 67.37. Not
accounting for drying agent.
4-Ethynyl-1-(hexyloxy)-2-nitrobenzene 7
9-{[3,4-Bis(hexyloxy)phenyl]ethynyl}-10-{[4-(hexyloxy)-3-
nitrophenyl]ethynylanthracene 1
In a screw capped vial equipped with a magnetic stirrer [4-
(hexyloxy)-3-nitrophenyl]ethynyltrimethylsilane 6 (0.159 g, 0.5
mmol) and SiO2-supported TBAF (0.0625 g, 0.05 mmol; 1.25
mmol g21) were added, and the resulting mixture was left
under vigorous stirring at 30 uC. After 3 h, ethyl acetate (1 ml)
was added. The catalyst was then filtered off and washed with
ethyl acetate (1.5 ml). The solvent was removed under vacuum
to give compound 9 as a yellow oil (0.118 g, 96% yield). 1H
NMR (CDCl3, d): 7.51 (m, 1H), 7.56 (m, 1H), 6.97 (m, 1H), 4.07
(m, 2H), 2.35 (s, 1H), 1.47 (m, 2H), 1.33 (m, 6H), 0.88 (m, 3H).
13C NMR (CDCl3, d): 153.7, 140.8, 138.1, 130.2, 114.8, 113.8,
79.2, 78.2, 70.5, 31.5, 29.4, 25.6, 22.6, 14.0. E-factor = [0.159 g
([4-(hexyloxy)-3-nitrophenyl]ethynyltrimethylsilane) + 0.0625 g
(TBAF/SiO2) + 2.25 g (ethyl acetate) 2 0.118 g (product 6
yield)]/0.118 g = 19.94.
In a screw-capped vial equipped with a magnetic stirrer 3,4-
bis(hexyloxy)ethynylbenzene 9 (0.130 g, 0.43 mmol), degassed
cyclopentyl methyl ether (CPME, 0.66 ml), bromo derivative 8
(0.196 g, 0.39 mmol), diisopropylamine (2.126 g, 21.06 mmol),
CuI (0.0029 g, 0.015 mmol), and PdEnCatTPP30 (0.082 g, 0.033
mmol) were consecutively added and the resulting mixture was
left under vigorous stirring at 50 uC. After 20 h, the crude
mixture was diluted with CHCl3 (2 ml), the catalyst was filtered
off, and the solvent removed under vacuum to give 9-bromo-
10-[4-hexyloxy-(3-nitrophenyl)ethynyl]anthracene 8. This latter
was purified by re-crystallization from ethyl acetate (2 6 25
ml) to give the pure compound as orange needles (0.197 g,
70% yield); m.p. 121–122u C. 1H NMR (CDCl3, d): 8.70 (m, 3H),
8.57 (m, 3H), 7.63 (m, 6H), 6.97 (m, 2H), 4.07(m, 6H), 1.85 (m,
6H), 1.50 (m, 6H), 1.34 (m, 6H), 0.92 (m, 9 H). 13C NMR (CDCl3,
d): 14.05, 22.54, 22.64, 25.47, 25.75, 28.83, 29.21, 29.31, 31.46,
31.63, 69.16, 69.48, 69.84, 84.97, 87.12, 99.59, 103.33, 113.29,
114.31, 115.38, 116.69, 119.29, 125.37, 126.59, 126.89, 127.31,
128.29, 131.75, 131.97, 136.725, 148.95, 150.28, 153.07. An.
Calcd. For: C48H53NO5: C, 79.64; H, 7.38; N, 1.93%. Found: C,
79.52; H, 7.37; N, 1.90%. E-factor = [0.130 g (3,4-bis(hexylox-
y)ethynylbenzene) + 0.196 g (8) + 0.57 g (cyclopentyl methyl
ether) + 0.0029 g (CuI) + 2.126 g (diisopropylamine) + 0.082 g
(PdEnCatTPP30) + 2.98 g (CHCl3) + 45.10 g (ethyl acetate) 2
0.197 g (product 6 yield)]/0.197 g = 258.8.
3,4-Bis(hexyloxy)ethynylbenzene 915
The desilylation reaction procedure described above for
preparing 7 is that used for preparing compound 9. Yield:
96% (yellow oil). 1H NMR (CDCl3, d): 0.85 (m, 6H), 1.34 (m,
12H), 1.75 (m, 4H), 2.93 (s, 1H), 3.92 (m, 4H), 6.73 (d, 1H, J =
8.2 Hz), 6.94 (m, 1H) 7.00 (dd, 1H, J = 1.9, 8.2 Hz). E-factor: see
ESI.
3
[3,4-Bis(hexyloxy)phenyl]ethynyl trimethylsilane 11
This compound was prepared by coupling 1,2-bis(hexyloxy)-4-
iodobenzene 1015 with trimethylsilylacetylene (1 : 1.5 molar
ratio), following the procedure described for 6. Yield: 99%
(yellow oil). 1H NMR (CDCl3, d): 0.19 (s, 9H), 0.85 (m, 6H), 1.34
(m, 12 H), 1.75 (m, 4H), 3.92 (m, 4H), 6.71 (d, 1H, J = 8.3 Hz),
6.91 (d, 1H, J = 1.9 Hz), 6.98 (dd, 1H, J = 1.9, 8.3 Hz). E-factor:
Device fabrication and measurements
OFET devices. Prime-grade n-doped silicon wafers having
300 nm thermally grown oxide (Process Specialties Inc.) were
used as device substrates. Before film deposition, the
substrates were cleaned by ultrasonic treatment with ethanol
and then in an oxygen plasma cleaner for 5 min under
vacuum. Films of compounds 1–4 were spin-coated from 0.5%
(w/v) CHCl3 solutions and, if annealed, heated under N2 at
various temperatures from 40 to 120 uC for 1 h, unless
otherwise noted. Spin-coated films were 30–40 nm thick as
determined by profilometry (Tencor P10). For FET device
fabrication, top contact gold (500 Å) were deposited by
evaporating gold (pressure , 1025 Torr); channel dimensions
see ESI.
3
9-Bromo-10-[4-hexyloxy-(3-nitrophenyl)ethynyl]anthracene 8
In a screw-capped vial equipped with a magnetic stirrer
4-ethynyl-1-(hexyloxy)-2-nitrobenzene 7 (0.106 g, 0.43 mmol),
degassed cyclopentyl methyl ether (CPME, 0.66 ml), 9-iodo-10-
bromoanthracene (0.149 g, 0.39 mmol), diisopropylamine
(1.063 g, 10.53 mmol), CuI (0.00074 g, 0.0039 mmol), and
PdEnCat30 (0.029 g, 0.011 mmol) were consecutively added
and the resulting mixture was left under vigorous stirring at 55
This journal is ß The Royal Society of Chemistry 2013
RSC Adv., 2013, 3, 9288–9295 | 9293